Motilal Oswal has maintained a positive outlook on Vinati Organics with a price target of ₹1,550, citing growth in the ATBS segment. While the company faces margin pressure from fluctuating raw material costs, future capacity expansion in October 2026 remains a key focus for investors. The stock currently trades at 23.8 times its estimated FY28 earnings.
Vinati Organics, a prominent player in the specialty chemicals sector, is currently being monitored by analysts for its growth potential in the Advanced Technical Boiling Point Styrene (ATBS) segment. Motilal Oswal recently maintained a positive outlook on the stock, setting a price target of ₹1,550. This assessment comes as the company navigates a period of margin volatility while pushing ahead with significant capacity expansions.
Impact of Margin Contraction and Revenue Trends
The company reported a 28% year-on-year revenue increase, highlighting strong demand for its product portfolio. However, profit margins have faced pressure, with EBITDA margins contracting by 500 basis points to reach 24.5% year-on-year. This decline is largely linked to the rising cost of raw materials, which has tempered the growth in operating profit. While EBITDA rose 7% to ₹1.7 billion, the narrowing of margins remains a factor for investors to track, as it reflects the challenge of passing on fluctuating input costs to customers in the competitive specialty chemicals space.
Growth Drivers and Capacity Expansion
Looking ahead, the ATBS segment is expected to remain the primary revenue driver for Vinati Organics. The company is actively working on scaling its production capabilities, with Phase I already in the ramp-up stage. A critical milestone for investors to monitor will be the commissioning of the Phase II expansion, which is scheduled for October 2026. Beyond ATBS, market analysts anticipate a gradual recovery in demand for the company’s other key product lines, specifically Butyl Phenol (BP) and Isobutyl Benzene (IBB), which have historically contributed to the firm's earnings base.
Financial Estimates and Valuation
Motilal Oswal has maintained its earnings forecasts for fiscal years 2027 and 2028. The brokerage projects a compound annual growth rate (CAGR) of 18% for revenue, 15% for EBITDA, and 13% for profit after tax between FY26 and FY28. On a valuation basis, the stock is trading at approximately 23.8 times its estimated FY28 earnings per share of ₹54.9. The Enterprise Value to EBITDA (EV/EBITDA) ratio is estimated at 15.4 times for the same period.
As the company moves toward the commissioning of its new capacity, the success of this expansion in maintaining utilization levels will be a key performance indicator. Investors will also watch for signs of stabilization in raw material prices, as any further cost inflation could continue to weigh on the company’s ability to improve its operating margins back toward historical levels.